NYSEAMERICAN:APHB - Ampliphi Biosciences Stock Price, News & Analysis

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume841,593 shs
Market Capitalization$148.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:APHB
CUSIPN/A
Phone+1-804-8272524

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees30
Market Cap$148.96 million
Next Earnings Date11/6/2019 (Estimated)
OptionableNot Optionable

Receive APHB News and Ratings via Email

Sign-up to receive the latest news and ratings for APHB and its competitors with MarketBeat's FREE daily newsletter.


Ampliphi Biosciences (NYSEAMERICAN:APHB) Frequently Asked Questions

What is Ampliphi Biosciences' stock symbol?

Ampliphi Biosciences trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "APHB."

How were Ampliphi Biosciences' earnings last quarter?

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) issued its earnings results on Monday, March, 25th. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.07. View Ampliphi Biosciences' Earnings History.

When is Ampliphi Biosciences' next earnings date?

Ampliphi Biosciences is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Ampliphi Biosciences.

What price target have analysts set for APHB?

1 analysts have issued 12 month price targets for Ampliphi Biosciences' stock. Their predictions range from $3.50 to $3.50. On average, they expect Ampliphi Biosciences' share price to reach $3.50 in the next year. View Analyst Price Targets for Ampliphi Biosciences.

What is the consensus analysts' recommendation for Ampliphi Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampliphi Biosciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ampliphi Biosciences.

Has Ampliphi Biosciences been receiving favorable news coverage?

News coverage about APHB stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ampliphi Biosciences earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Ampliphi Biosciences.

Who are some of Ampliphi Biosciences' key competitors?

What other stocks do shareholders of Ampliphi Biosciences own?

Who are Ampliphi Biosciences' key executives?

Ampliphi Biosciences' management team includes the folowing people:
  • Dr. Paul C. Grint, CEO & Director (Age 61)
  • Mr. Steven R. Martin, Sr. VP & CFO (Age 58)
  • Mr. Michael Scott Salka, Consultant (Age 57)

How do I buy shares of Ampliphi Biosciences?

Shares of APHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

How big of a company is Ampliphi Biosciences?

Ampliphi Biosciences has a market capitalization of $0.00. Ampliphi Biosciences employs 30 workers across the globe.View Additional Information About Ampliphi Biosciences.

What is Ampliphi Biosciences' official website?

The official website for Ampliphi Biosciences is http://www.ampliphibio.com/.

How can I contact Ampliphi Biosciences?

Ampliphi Biosciences' mailing address is 3579 Valley Centre Drive, SAN DIEGO, CA 92130, United States. The biotechnology company can be reached via phone at +1-804-8272524.


MarketBeat Community Rating for Ampliphi Biosciences (NYSEAMERICAN APHB)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  129 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about Ampliphi Biosciences and other stocks. Vote "Outperform" if you believe APHB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel